Free Trial

HEALTHCARE: Sanofi (SANFP: A1 pos / AA): Consumer Unit Sale Proceeding

HEALTHCARE

"Market Chatter: Sanofi Invites Initial Bids for $20 Billion Consumer Spinoff" - MT Newswires

  • This has been known about for a while but is nearing completion.
  • Sanofi is heavily dependent on Dupixent (Asthma medication) for 28% of it sales and will need to use proceeds of the consumer unit sales to develop alternative remedies.
  • Sanofi is said to be keeping a significant minority stake in the consumer unit which, presumably, will be a source of liquidity in the future.
  • Last issued Mar '22. WtgAvg debt is 4.3yrs vs 11.9 yrs at JNJ... They will need to extend near-term maturities soon.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.